Regulatory

As you review and strengthen GMP compliance in worldwide markets, we can help with specific projects such as bringing regulatory filings and submissions up to standard.

Evolving Regulatory Requirements

Our deeply-experienced Regulatory experts can provide help right across the regulatory lifecycle, to ensure that dossiers are up to scratch pre-, during, and post-submission.

From initial dossier review and gap analysis, to hands-on help with eCTD submissions, to longer-term variation management, we’ll help you accelerate market delivery and maintain ongoing compliance.

We can provide these services for both drug substances and for finished drug products.

What Rephine Offers

REPHINE REGULATORY PURP PRE SUBM REVIW ICON

Pre-submission review

We’ll review your dossier and provide a detailed gap analysis so that you can ensure your submissions are successful first time.

REPHINE REGULATORY PURP SUBMISSION SUPPORT ICON

Submission support

Our experts can help you fill any gaps, draft content as needed, and submit the finished dossier to the relevant agencies in the correct eCTD format.

REPHINE REGULATORY PURP POST SUBM LIFECYCLE ICON

Post-submission lifecycle management

We’ll help you maintain compliance on an ongoing basis, ensuring robust variations management and continuous tracking of evolving authority requirements.

Where do you Need our Help?

For GMP Auditing, Quality Assurance & Digitalisation, we’re the partner of choice for all the stakeholders we deal with.

We provide extensive GMP consulting services to help keep our clients ahead of the needs and expectations of regulators.

REPHINE AUDIT GREEN GAP ANALYSIS ICON

Global Audit Library

Explore our extensive GMP audit library to see the range and scope of live reports we have in stock, join a live audit, or commission a bespoke audit

REPHINE AUDIT GREEN AUDIT REPORT LIBRARY ICON

GMP Audit Services

Maintain high standards of life sciences manufacturing supplier qualifications and GMP auditing within the supply chain through our expertise

REPHINE AUDIT BLUE INOVATION CONVOS ICON

GxP Consultancy

Discover how we can help your product reach to market, fully and demonstrably complying with the latest GxP standards

REPHINE DIGITALISATION PURP POST SUBM LIFECYCLE ICON

Digitalisation

From data integrity to implementing new systems, our experienced team with a digital mindset, can lead you to transformative achievements

Related Resources

Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Digital QMS Transformation for Biopharmaceutical CDMO

A leading biopharmaceutical CDMO partnered with Rephine to replace manual quality processes with a validated digital QMS, improving efficiency and compliance. Learn how the two-phase ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Validating AI Models in Pharma: Annex 22 & GxP Compliance

As AI integrates into pharma manufacturing, Annex 22 sets new expectations for validation. Learn how to ensure reliable models with strong data, oversight, and compliance.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

How to Prepare for Annex 22: EMA’s AI and Machine Learning Guidance for Pharma Manufacturing

The EMA’s draft Annex 22 marks the first regulatory framework for AI and machine learning in GxP manufacturing. Learn the key requirements, from model validation ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Enhancing Data Integrity Under EMA’s Revised Annex 11: Audit Trail & ALCOA+ Controls

The EMA’s 2025 draft revision of Annex 11 raises the bar on data integrity and audit trail controls. Learn how to ensure full traceability, system-generated ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Annex 11 2025: System Lifecycle & Supplier Oversight

With the EMA’s 2025 update to Annex 11, lifecycle management and supplier oversight of GxP-regulated computerised systems are under sharper regulatory focus. Find out how ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

EMA’s Annex 22: AI in Pharma Gets a GxP Rulebook

The EMA's draft Annex 22 introduces the first GxP framework for AI and machine learning in pharma. Learn what it means for validation, oversight, and ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

GMP Chapter 22: Adapting to Hybrid Documentation Standards

The new EU GMP Chapter 4 expands documentation beyond paper to include hybrid formats, digital media, and multimedia files. Learn what it means for GxP ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

EMA vs USFDA: AI Compliance in GxP Pharma Environments

With AI reshaping pharma, global firms must align with both EMA and USFDA guidance. This article unpacks the regulatory differences and offers practical tips for ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

EMA Draft Revisions to EU GMP: Annex 11, Annex 22 & AI

The EMA has launched public consultation on major EU GMP updates, including new requirements for AI, documentation, and computerised systems. Here’s what pharma and biotech ...
Read More

Let's get in touch

Please get in touch. Our expert GMP audit team is only a click away, on standby to answer all your questions.
Social: Linkedin

REPHINE HQ

REPHINE BARCELONA S.L.U

  • Barcelona, Spain                               
  • +34 934 178065

REPHINE CHINA

  • Shanghai, China 

REPHINE INDIA

  • Hyderabad, India                               

Contact Us